What are the goals of drug treatment for benign prostatic hyperplasia (BPH)?

Updated: Feb 19, 2021
  • Author: Levi A Deters, MD; Chief Editor: Edward David Kim, MD, FACS  more...
  • Print

The goals of pharmacotherapy for benign prostatic hypertrophy (BPH) are to reduce morbidity and to prevent complications. The agents used include the following, alone or in combination:

  • Alpha-adrenergic blockers
  • 5-Alpha-reductase inhibitors
  • Phosphodiesterase-5 enzyme inhibitors

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!